Development of NR0B2 as a therapeutic target for the re-education of tumor associated myeloid cells. Vidana Gamage HE, Albright ST, Smith AJ, Farmer R, et al. Cancer Lett 2024;597:217086.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Vidana Gamage HE, Albright ST, Smith AJ, Farmer R, et al. Development of NR0B2 as a therapeutic target for the re-education of tumor associated myeloid cells. Cancer Lett 2024;597:217086.
PMID: 38944231